Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-07-11

Clinical Trial Update: Androxal in Male Infertility [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates the Androxal program for male infertility has been withdrawn after Phase 2/Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Androxal (enclomiphene citrate)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Infertility | Phase 2, Phase 3 | Status: WITHDRAWN